Current Cardiology Reports

, Volume 7, Issue 4, pp 270–275 | Cite as

Issues with care in the elderly patient presenting with acute ischemia

  • S. Michael Gharacholou
  • Karen P. Alexander


The issues surrounding care of the elderly patient with acute coronary syndromes (ACS) present significant challenges to clinicians and investigators. The elderly often have atypical symptoms of acute ischemia, have greater medical comorbidities, and are more likely to die from ischemic heart disease. Important differences exist among elderly patients with ACS as compared with their younger counterparts, including age-related changes in physiology, metabolism of drugs, and overall functional status, all of which influence treatment patterns and clinical outcomes. Given the absence of elderly patients in many clinical trials, these high-risk individuals are sometimes managed with more conservative strategies, which at times diverge from accepted guidelines. This review addresses clinically important issues in the care of elderly patients with acute ischemia and highlights recent studies that provide new insight into this complex area of cardiovascular care.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kochanek KD, Smith BL: Deaths: Preliminary Data for 2002. National Vital Statistics Reports, vol 52, no 13. Hyattsville, MD: National Center for Health Statistics; 2004.Google Scholar
  2. 2.
    Gurwitz JH, Goldberg RJ, Chen Z, et al.: Recent trends in hospital mortality of acute myocardial infarction-the Worcester Heart Attack Study: have improvements been realized for all age groups? Arch Intern Med 1994, 154:2202–2208.PubMedCrossRefGoogle Scholar
  3. 3.
    Goldberg RJ, Yarzebski J, Lessard D, Gore JM: A two-decades (1975-1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999, 33:1533–1539.PubMedCrossRefGoogle Scholar
  4. 4.
    Lee PY, Alexander KP, Hammill BG, et al.: Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001, 286:708–713.PubMedCrossRefGoogle Scholar
  5. 5.
    Brieger D, Eagle KA, Goodman SG, et al., for the GRACE Investigators: Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest 2004, 126:461–469. Report from GRACE of characteristics and outcomes of patients who present with atypical symptoms defined as lack of chest pain. Particularly important for its implications to elderly populations with ischemia.PubMedCrossRefGoogle Scholar
  6. 6.
    Kannel WB, Abbott RD: Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984, 311:1144–1147.PubMedCrossRefGoogle Scholar
  7. 7.
    Goldberg RJ, Yarzebski J, Lessard D, Gore JM: Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med 2000, 160:3217–3223.PubMedCrossRefGoogle Scholar
  8. 8.
    Goff DC, Feldman HA, McGovern PG, et al., for the Rapid Early Action for Coronary Treatment (REACT) study group: Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Am Heart J 1999, 138:1046–1057.PubMedCrossRefGoogle Scholar
  9. 9.
    Grossman SA, Brown DF, Chang Y, et al.: Predictors of delay in presentation to the ED in patients with suspected acute coronary syndromes. Am J Emerg Med 2003, 21:425–428.PubMedCrossRefGoogle Scholar
  10. 10.
    Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992, 326:242–250, 310–318.PubMedCrossRefGoogle Scholar
  11. 11.
    Braunwald E: Unstable angina: an etiologic approach to management. Circulation 1998, 98:2219–2222.PubMedGoogle Scholar
  12. 12.
    Alexander KP, Biswas MS: Heart failure and the elderly: disease diversity, data, and delivery of care. Am Heart J 2003, 146:194–196.PubMedCrossRefGoogle Scholar
  13. 13.
    Aurigemma GP, Gaasch WH: Diastolic heart failure. N Engl J Med 2004, 351:1097–1105.PubMedCrossRefGoogle Scholar
  14. 14.
    Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777–781.PubMedCrossRefGoogle Scholar
  15. 15.
    Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension 2002, 39:10–15.PubMedCrossRefGoogle Scholar
  16. 16.
    Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346–354.PubMedCrossRefGoogle Scholar
  17. 17.
    Blackwell KA, Sorenson JP, Richardson DM, et al.: Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2004, 287:H2448-H2453.PubMedCrossRefGoogle Scholar
  18. 18.
    Mari D, Mannucci PM, Coppola B, et al.: Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995, 85:3144–3149.PubMedGoogle Scholar
  19. 19.
    Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina); 2002. Available at unstable/unstable.pdfGoogle Scholar
  20. 20.
    Antman EM, Anbe DT, Armstrong PW, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/ AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2004, 44:671–719.PubMedCrossRefGoogle Scholar
  21. 21.
    Fried LP, Tangen CM, Walston J, et al., for the Cardiovascular Health Study Collaborative Research Group: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146–156.PubMedGoogle Scholar
  22. 22.
    Walston J, McBurnie MA, Newman A, et al.: Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002, 162:2333–2341. Report of findings in the Cardiovascular Health Study linking syndrome of frailty to inflammatory and coagulation activation.PubMedCrossRefGoogle Scholar
  23. 23.
    Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebocontrolled trial. Lancet 2002, 360:7–22.CrossRefGoogle Scholar
  24. 24.
    Montamat SC, Cusack BJ, Vestal RE: Management of drug therapy in the elderly. N Engl J Med 1989, 321:303–309.PubMedCrossRefGoogle Scholar
  25. 25.
    Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998, 339:799–805.PubMedCrossRefGoogle Scholar
  26. 26.
    Sorensen CR, Brendorp B, Rask-Madsen C, et al.: The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002, 23:948–952.PubMedCrossRefGoogle Scholar
  27. 27.
    Al Suwaidi J, Reddan DN, Williams SK, et al.: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002, 106:974–980.PubMedCrossRefGoogle Scholar
  28. 28.
    Beattie JN, Soman SS, Sandberg KR, et al.: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001, 37:1191–1200.PubMedGoogle Scholar
  29. 29.
    Santopinto JJ, Fox KAA, Goldberg RJ, et al., for the GRACE Investigators: Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003, 89:1003–1008.PubMedCrossRefGoogle Scholar
  30. 30.
    Shlipak MG, Heidenreich PA, Noguchi H, et al.: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002, 137:555–562.PubMedGoogle Scholar
  31. 31.
    Pinsky JL, Jette AM, Branch LG, Kannel WB: The Framingham disability study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health 1990, 80:1363–1367.PubMedCrossRefGoogle Scholar
  32. 32.
    Ferrucci L, Guralnik JM, Studenski S, et al., for the Interventions on Frailty Working Group: Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 2004, 52:625–634.PubMedCrossRefGoogle Scholar
  33. 33.
    Ades PA: Introduction-the elderly in cardiac rehabilitation. Am J Geriatr Cardiol 1999, 8:61–62.PubMedGoogle Scholar
  34. 34.
    Gurwitz JH, Col NF, Avorn J: The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992, 268:1417–1422.PubMedCrossRefGoogle Scholar
  35. 35.
    Bowling A: Ageism in cardiology. BMJ 1999, 319:1353–1355.PubMedGoogle Scholar
  36. 36.
    Yusuf S, Furberg CD: Are we biased in our approach to treating elderly patients with heart disease? Am J Cardiol 1991, 68:954–956.PubMedCrossRefGoogle Scholar
  37. 37.
    Alter DA, Manuel DG, Gunraj N, et al.: Age, risk-benefit tradeoffs, and the projected effects of evidence based therapies. Am J Med 2004, 116:540–545. An assessment of the extrapolation of trial data to populations not studied, specifically the elderly, which emphasized that their increased burden of disease makes the elderly likely to achieve similar or greater benefit from therapy despite lack of representation in trials.PubMedCrossRefGoogle Scholar
  38. 38.
    Ohman EM, Roe MT, Smith SC, et al., for the CRUSADE Investigators: Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative. Am Heart J 2004, 148:S34-S39.PubMedCrossRefGoogle Scholar
  39. 39.
    Fibrinolytic Therapy Trialists' (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994, 343:311–322.Google Scholar
  40. 40.
    Eagle KA, Goodman SG, Avezum A, et al., for the GRACE Investigators: Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373–377.PubMedCrossRefGoogle Scholar
  41. 41.
    Barron HV, Bowlby LJ, Breen T, et al.: Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 1998, 97:1150–1156.PubMedGoogle Scholar
  42. 42.
    White HD: Thrombolytic therapy in the elderly. Lancet 2000, 356:2028–2030.PubMedCrossRefGoogle Scholar
  43. 43.
    Gore JM, Granger CB, Simoons ML, et al., for the GUSTO-I Investigators: Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Circulation 1995, 92:2811–2818.PubMedGoogle Scholar
  44. 44.
    Cohen M, Demers C, Gurfinkel EP, et al., for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447–452.PubMedCrossRefGoogle Scholar
  45. 45.
    Antithrombotic Trialists' Collaboration: Collaborative metaanalysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71–86.CrossRefGoogle Scholar
  46. 46.
    Krumholz HM, Radford MJ, Ellerbeck EF, et al.: Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Circulation 1995, 92:2841–2847.PubMedGoogle Scholar
  47. 47.
    Boersma E, Harrington RA, Moliterno DJ, et al.: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 2002, 359:189–198.PubMedCrossRefGoogle Scholar
  48. 48.
    Hasdai D, Holmes DR Jr, Criger DA, et al., for the PURSUIT Trial Investigators: Age and outcome after acute coronary syndromes without persistent ST-segment elevation. Am Heart J 2000, 139:858–866.PubMedCrossRefGoogle Scholar
  49. 49.
    Peterson ED, Pollack CV, Roe MT, et al.: Early use of glycoprotein IIb/IIIa inhibitors in non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2003, 42:45–53.PubMedCrossRefGoogle Scholar
  50. 50.
    Bach RG, Cannon CP, Weintraub WS, et al.: The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004, 141:186–195. An analysis of benefit and risk of invasive or conservative management strategy in the elderly (age Y 65 years) in the TACTICS-TIMI-18 study, which demonstrates routine early invasive therapy improves ischemic outcomes with an associated risk of bleeding.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • S. Michael Gharacholou
  • Karen P. Alexander
    • 1
  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations